RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ASND
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Stronger technical forecast for Ascendis Pharma A/S stock price after Thursday trading.
(Updated on Mar 28, 2024)

Buy candidate since Mar 28, 2024 PDF

The Ascendis Pharma A/S stock price gained 1.84% on the last trading day (Thursday, 28th Mar 2024), rising from $148.44 to $151.17. During the last trading day the stock fluctuated 4.79% from a day low at $144.66 to a day high of $151.59. The price has fallen in 7 of the last 10 days but is still up by 0.85% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 54 thousand more shares were traded than the day before. In total, 295 thousand shares were bought and sold for approximately $44.56 million.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 16.84% during the next 3 months and, with a 90% probability hold a price between $170.10 and $197.45 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ASND Signals & Forecast

The Ascendis Pharma A/S stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $147.07 and $149.27. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, February 23, 2024, and so far it has fallen -5.16%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Ascendis Pharma A/S stock

On the downside, the stock finds support just below today's level from accumulated volume at $139.29 and $132.40. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Ascendis Pharma A/S finds support just below today's level at $139.29. If this is broken, then the next support from accumulated volume will be at $132.40 and $129.93.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $6.93 (4.79%) between high and low. For the last week, the stock has had daily average volatility of 3.21%.

Our recommended stop-loss: $144.71 (-4.27%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 24 days ago.)

Trading Expectations (ASND) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Ascendis Pharma A/S to open at $149.14, and during the day (based on 14 day Average True Range), to move between $146.27 and $156.07, which gives a possible trading interval of +/-$4.90 (+/-3.24%) up or down from last closing price. If Ascendis Pharma A/S takes out the full calculated possible swing range there will be an estimated 6.48% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $152.47 (0.86%) than the support at $139.29 (7.86%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Ascendis Pharma A/S stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Ascendis Pharma A/S stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 1.729 Buy Candidate Upgraded

Predicted Opening Price for Ascendis Pharma A/S of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$149.14 ( 1.34%) $151.17

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ASND

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 156.07 3.24 %
R2 153.42 1.49 %
R1 151.79 0.408 %
Current price: 151.17
Support S1 146.49 -3.09 %
S2 144.86 -4.18 %
S3 142.21 -5.93 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 158.20 4.65 %
R2 156.39 3.45 %
R1 152.47 0.86 %
Current price 151.17
Support S1 139.29 -7.86%
S2 132.40 -12.42%
S3 129.93 -14.05%

FAQ

What is the symbol for Ascendis Pharma A/S Stock and on which exchange is it traded?
The symbol for Ascendis Pharma A/S is ASND and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Ascendis Pharma A/S Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Ascendis Pharma A/S stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

How to buy Ascendis Pharma A/S Stock?
Ascendis Pharma A/S Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Ascendis Pharma A/S Stock.

What's the current price of Ascendis Pharma A/S Stock?
As of the end of day on the 2024-03-28, the price of an Ascendis Pharma A/S (ASND) share was $151.17.

What is the 52-week high and low for Ascendis Pharma A/S Stock?
The 52-week high for Ascendis Pharma A/S Stock is $161.00 and the 52-week low is $64.33.

What is the market capitalization of Ascendis Pharma A/S Stock?
As of the 2024-03-28, the market capitalization of Ascendis Pharma A/S is 8.558B.

When is the next earnings date for Ascendis Pharma A/S?
The upcoming earnings date for Ascendis Pharma A/S is Apr 25, 2024.
Click to get the best stock tips daily for free!

About Ascendis Pharma A/S

Ascendis Pharma A/S Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra... ASND Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT